Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancerMiguel A. Zaballos, Pilar Santisteban|Endocrine Related Cancer|2019Cited by 38
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancerMiguel A. Zaballos, Pilar Santisteban|Cellular and Molecular Life Sciences|2022Cited by 11